scanX
Home
Neuland Laboratories

Neuland Laboratories

13,008.15
+599.30
(4.83%)
Market Cap (₹ Cr.)
₹15,754
52 Week High
13,221.70
Book Value
₹999
52 Week Low
3,611.10
PE Ratio
49.15
PB Ratio
12.29
PE for Sector
42.57
PB for Sector
22.37
ROE
23.39 %
ROCE
45.58 %
Dividend Yield
0.11 %
EPS
₹249.83
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
30.82 %
Net Income Growth
83.51 %
Cash Flow Change
10.10 %
ROE
42.22 %
ROCE
63.11 %
EBITDA Margin (Avg.)
28.98 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
134
124
128
123
136
150
150
133
139
118
130
123
161
155
169
172
174
182
187
205
194
206
242
246
259
203
258
238
257
222
294
270
415
365
421
395
390
465
Expenses
113
103
109
104
115
125
124
117
111
107
116
113
141
145
154
156
154
162
161
176
162
172
201
199
219
175
215
204
217
193
225
215
287
266
280
272
278
316
EBITDA
21
22
20
19
21
25
25
16
29
11
14
10
19
10
15
16
20
19
25
29
32
34
41
47
40
28
43
34
39
29
69
55
128
99
140
123
112
149
Operating Profit %
8 %
14 %
12 %
10 %
15 %
16 %
17 %
11 %
20 %
7 %
11 %
8 %
12 %
6 %
9 %
9 %
11 %
10 %
13 %
14 %
16 %
16 %
17 %
19 %
10 %
13 %
17 %
14 %
15 %
13 %
24 %
20 %
29 %
27 %
33 %
31 %
28 %
28 %
Depreciation
4
4
4
4
4
4
5
5
5
5
6
6
6
6
6
7
7
8
8
8
8
9
9
10
11
12
12
13
12
13
13
13
13
14
15
15
16
16
Interest
9
7
6
6
5
6
5
5
5
5
5
5
5
4
4
3
5
4
5
6
7
5
4
4
5
4
4
3
3
3
3
3
4
2
4
4
4
3
Profit Before Tax
9
11
9
9
12
14
15
6
19
1
4
0
9
1
5
6
8
8
12
16
17
20
29
32
24
12
28
18
24
13
53
39
110
84
121
104
92
130
Tax
3
4
3
3
4
5
5
3
-2
1
2
-0
1
0
1
2
2
2
3
3
-8
0
3
4
5
3
6
4
7
4
14
7
25
21
31
25
22
31
Net Profit
6
7
6
6
7
10
10
4
15
1
2
1
8
0
4
5
7
6
9
11
-9
15
21
27
17
9
20
13
22
10
38
30
85
62
89
81
68
98
EPS in ₹
6.40
8.22
6.98
7.00
7.46
10.70
11.52
4.09
13.17
0.58
2.15
0.66
7.22
0.35
3.43
3.59
5.25
4.38
6.68
8.61
-7.29
11.74
16.63
20.79
13.43
6.74
15.84
10.08
17.01
7.67
29.88
23.81
65.87
48.50
69.42
62.90
52.70
76.65
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
511
523
885
1,071
1,130
1,230
1,324
1,382
1,579
1,831
Fixed Assets
123
139
466
475
541
653
716
767
758
824
Current Assets
315
313
374
447
453
514
548
579
760
919
Capital Work in Progress
41
40
20
126
104
24
17
20
41
46
Investments
0
0
8
8
8
8
7
4
1
1
Other Assets
347
344
392
462
476
545
583
590
781
960
Total Liabilities
351
339
342
516
434
524
542
547
591
554
Current Liabilities
297
270
288
370
331
362
373
368
446
434
Non Current Liabilities
55
69
54
146
103
162
169
178
145
121
Total Equity
160
184
543
555
696
706
782
836
988
1,277
Reserve & Surplus
151
175
534
546
683
693
769
823
975
1,264
Share Capital
9
9
9
9
13
13
13
13
13
13
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
1
-3
0
4
2
-9
3
41
41
Investing Activities
-14
-20
-42
-116
-77
-49
-84
-96
-62
-150
Operating Activities
13
45
39
12
70
57
189
60
239
260
Financing Activities
1
-24
-0
105
12
-5
-114
38
-136
-69
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
36.22 %
36.22 %
36.22 %
36.22 %
36.22 %
36.22 %
36.22 %
36.14 %
36.14 %
36.03 %
35.97 %
32.80 %
32.74 %
32.72 %
FIIs
17.19 %
15.49 %
16.01 %
17.19 %
17.19 %
17.37 %
17.68 %
17.70 %
18.13 %
20.19 %
21.57 %
22.69 %
24.44 %
25.72 %
DIIs
5.32 %
4.44 %
5.67 %
6.19 %
6.40 %
6.47 %
6.58 %
6.55 %
7.10 %
6.76 %
6.99 %
6.03 %
6.54 %
6.39 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.44 %
0.46 %
0.40 %
0.40 %
0.40 %
0.40 %
0.40 %
0.40 %
Public / Retail
41.27 %
43.85 %
42.10 %
40.40 %
40.19 %
39.94 %
39.08 %
39.15 %
38.23 %
36.62 %
35.07 %
38.08 %
35.88 %
34.76 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,868.10 4,46,864.13 42.38 49,887.17 12.06 9,648 42.62 67.27
Divis Laboratories
5,375.80 1,42,624.31 85.20 8,184.00 0.89 1,600 20.79 63.25
Cipla
1,637.55 1,33,866.34 30.12 26,520.66 14.17 4,155 17.77 53.84
Dr Reddys Laboratories
6,650.35 1,10,964.30 19.94 28,905.40 12.36 5,578 -0.90 45.69
Mankind Pharma
2,734.30 1,06,222.78 54.13 10,615.63 19.57 1,942 9.89 74.75
Zydus Life Science
1,051.55 1,06,152.65 25.46 19,831.50 13.82 3,831 30.78 29.31
Lupin
2,215.75 99,523.63 43.97 20,141.50 19.94 1,936 77.69 56.52
Aurobindo Pharma
1,501.15 86,724.77 24.18 29,559.25 17.55 3,169 61.17 46.63
Alkem Laboratories
6,046.80 71,491.50 33.26 12,978.42 9.84 1,811 91.18 50.66
Glenmark Pharmaceuticals
1,697.50 48,293.68 - 12,653.09 6.58 -1,831 96.52 56.39

Corporate Action

Technical Indicators

RSI(14)
Neutral
64.01
ATR(14)
Volatile
475.88
STOCH(9,6)
Neutral
60.90
STOCH RSI(14)
Oversold
19.65
MACD(12,26)
Bearish
-106.08
ADX(14)
Strong Trend
45.92
UO(9)
Bearish
55.24
ROC(12)
Uptrend And Accelerating
0.80
WillR(14)
Overbought
-18.91
Bearish
3
Neutral
2
Bullish
3
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Candlestick Screeners
Technical Screeners
Price & Volume Screeners
Intraday Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.